SCG Cell Therapy

Singapore, Singapore

SCG Cell Therapy goal is to prevent and treat cancer by using the immune system of the patient to target pathogenic infections.

$8.1M raised

Apr 2023

Series C

Biotechnology Life Science

Top Investors

Smartech Investment Holdings

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SCG Cell Therapy

How much funding has SCG Cell Therapy raised?

SCG Cell Therapy has raised $8.1M in total funding. The most recent round was Series C. The last funding was announced in April 2023.

Who are SCG Cell Therapy's investors?

SCG Cell Therapy's investors include Smartech Investment Holdings.

Where is SCG Cell Therapy headquartered?

SCG Cell Therapy is headquartered in Singapore, Singapore.

What does SCG Cell Therapy do?

SCG Cell Therapy goal is to prevent and treat cancer by using the immune system of the patient to target pathogenic infections.

What stage is SCG Cell Therapy at?

SCG Cell Therapy is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 5, 2023.

MLA

"SCG Cell Therapy — Funding & Investors." VCBacked, April 5, 2023, https://www.vcbacked.co/company/scg-cell-therapy. Accessed July 16, 2026.

APA

VCBacked. (2023). SCG Cell Therapy — Funding & Investors. Retrieved July 16, 2026, from https://www.vcbacked.co/company/scg-cell-therapy

Wikipedia (cite web)

{{cite web |title=SCG Cell Therapy — Funding & Investors |url=https://www.vcbacked.co/company/scg-cell-therapy |website=VCBacked |access-date=July 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 5, 2023.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K